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The mechanism of oxygen toxicity for central nervous system and hyperbaric oxygen (HBO) seizure 
has not been clariﬁed.  Noradrenergic cells in the brain may contribute to HBO seizure.  In this study,  
we deﬁned the activation of noradrenergic cells during HBO exposure by c-fos immunohistochemistry.  
Electroencephalogram electrodes were pre-implanted in all animals under general anesthesia.  In HBO 
seizure animals,  HBO was induced with 5 atm of 100ｵ oxygen until manifestation of general tonic 
convulsion.  HBO non-seizure animals were exposed to 25 min of HBO.  Control animals were put in the 
chamber for 120 min without pressurization.  All animals were processed for c-fos immunohistochemi-
cal staining.  All animals in the HBO seizure group showed electrical discharge on EEG.  In the immu-
nohistochemistry,  c-fos was increased in the A1,  A2 and A6 cells of the HBO seizure group,  and in the 
A2 and A6 cells of the HBO non-seizure group,  yet was extremely low in all three cell types in the 
control group.  These results suggest the participation of noradrenaline in HBO seizure,  which can be 
explained by the early excitement of A1 cells due to their higher sensitivity to high blood pressure,  
hyperoxia,  or by the post-seizure activation of all noradrenergic cells.
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yperbaric oxygen (HBO) therapy has been per-
formed as a unique treatment for carbon monox-
ide poisoning [1-3],  caisson sickness [4],  and gas 
gangrene [5-7].  In addition,  it has been reported 
that HBO improves the outcome in cerebral infarction 
as well [2,  8].  In spite of those beneﬁts of HBO 
treatment,  the clinical application of HBO is extremely 
limited due to oxygen (O2) toxicity to the central ner-
vous system (CNS) and respiratory system.  The spe-
ciﬁc symptoms of CNS O2 toxicity at 2 or 3 atm pure 
oxygen are characterized as generalized tonic convul-
sion.  A higher oxygen pressure or longer exposure 
period increases the incidence of the convulsion [9,  
10].
　 In spite of recent trials to elucidate the nature of 
O2 toxicity,  the mechanism of HBO seizure has not 
been clariﬁed yet.  The possible causes are considered 
to be production of reactive oxygen species (ROS) 
including nitric oxide (NO) [11,  12],  decrease of 
gamma-aminobutyric acid (GABA) [13,  14],  and col-
lapse of the catecholamine system in the brain [15,  
16].
　 The contribution of catecholamines,  especially 
noradrenaline,  has received attention after a report 
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that administration of a β-adrenergic blockade reduces 
the incidence of HBO-induced seizures [17].  From 
this result,  we hypothesized that the noradrenergic 
cells in the rat brain would contribute to HBO sei-
zure.
　 In this study,  we examined the activation of nora-
drenergic cell groups (A1,  A2,  and A6) in the rat 
brain during HBO exposure by measuring Fos expres-
sion,  a major immunohistochemical marker for neu-
ronal excitation in seizure models.
Materials and Methods
　 Fifteen male Wistar rats (Charles River Japan,  
Yokohama,  Japan) were used in this study.  The ani-
mals were fed ad libitum before the experiments.  All 
experiments were performed in accordance with the 
National Institutes of Health animal care guidelines 
and were approved by the Animal Research Control 
Committee of Okayama University Medical School.
　 General procedures. All animals were 
implanted with EEG electrodes under anesthesia with 
a mixture of 2ｵ halothane and 50ｵ oxygen/50ｵ 
nitrogen a day before HBO procedures.  The continu-
ously measured EEGs (S1516,  Nihon Kohden Kogyo 
Co.  Ltd.,  Tokyo,  Japan) were collected and analyzed 
using an analog-digital system (AxoScope and Digidata 
1200B; Axon Instruments,  Inc.,  Foster City,  CA,  
USA).
　 After the HBO procedure,  EEG data was collected 
and typical wave signals were analyzed for 3 periods
－pre-pressurization as control; just after plateau 
pressure was reached,  and during seizure－using 
power-analyzing software (Origin Pro 8,  Origin Lab 
Corporation,  Northampton,  MA,  USA).
　 HBO procedure. A 300-liter chamber for 
HBO (PHC-special products,  TABAI,  Tokyo,  Japan) 
was used.  Before HBO administration on animals,  the 
chamber was ﬂushed twice with pure oxygen up to 2 
atmospheres absolute (atm abs) pressure.  In pressur-
ized groups,  each animal was pressurized to 5 atm abs 
with 100ｵ oxygen.  After the pressure of 5 atm abs 
was reached,  continuous O2 ﬂow of 0.5L/min was 
administrated to prevent accumulation of CO2 in the 
chamber.  The temperature inside the chamber was 
kept at 24±2℃ with a heated water blanket.  During 
HBO,  animals were visually observed through an 
illuminator on the chamber and all changes in their 
behavior were recorded.
　 Rats were randomly divided into 3 groups (n＝
5per group): HBO seizure,  HBO non-seizure,  and 
controls.  Animals in the HBO seizure group were 
pressurized for 120 minutes or until manifestation of 
wild running,  a severe and fatal type of HBO seizure.  
During wild running,  rats show running and jumping 
motions followed by general tonic seizure.  Animals in 
the HBO non-seizure group were exposed to 25min of 
HBO with 100ｵ oxygen.  The period of 5 atm abs in 
this procedure was 5min.  The time course of pres-
surization in the HBO non-seizure group was deter-
mined from the preliminary result of the ﬁrst EEG 
seizure in HBO.  Animals in the control group were 
put in the chamber for 120min without pressuriza-
tion.
　 Immunohistochemistry. Following completion 
of HBO procedures,  all animals were processed for 
immunohistochemical staining.  At 2h after removal 
from the chamber,  animals were transcardially perfu-
sion-ﬁxed with 4ｵ paraformaldehyde in 0.1M phos-
phate buﬀer (pH7.4) under urethane anesthesia.  
Brains were rapidly removed from the skull and post-
ﬁxed in the same solution for 12h.  Five-mm coronal 
blocks were cut out and embedded in paraﬃn wax.  A1,  
A2,  and A6 were sectioned using a microtome (micro-
tome RV-240,  YAMATO,  Asaka,  Saitama,  Japan) at 
5-µm thickness and mounted on glass slides.  Locations 
of collecting area were referred to rat brain (Paxinos 
and Watson,  1997).
　 Paraﬃn sections were pretreated with xylene and 
ethanol in adequate concentrations,  rinsed in 0.01M 
phosphate buﬀered saline (PBS) (pH7.4,  Sigma,  St.  
Louis,  MS,   USA),  placed in 0.1ｵ Triton X-100 for 
5min,  rinsed again in PBS,  and placed in 5ｵ normal 
donkey serum in PBS for 1h.  Then,  they were incu-
bated in a mixture of primary antibodies for 48h at 
4℃,  rinsed in PBS,  incubated in a mixture of sec-
ondary antibodies for 4h at room temperature,  rinsed 
in PBS,  and coverslipped with an antifade mounting 
medium (Prolong Gold,  Eugene,  OR,  USA).
　 A rabbit anti-c-fos polyclonal antibody (sc-52,  
Santa Cruz Biotechnology,  Santa Cruz,  CA,  USA) 
and mouse anti-tyrosine hydroxylase polyclonal anti-
body (MAB318,  Chemicon International Ltd.,  
Harrow,  UK) were used as the primary antibodies at 
dilutions of 1 : 200 and 1 : 100,  respectively.
　 The secondary antibody,  donkey anti-rabbit-IgG 
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antibody,  was labeled by Cy3 (Ab-182C,  Chemicon 
International Ltd.,  Harrow,  UK , 1 : 50 dilution),  and 
donkey anti-mouse-IgG antibody was labeled by FITC 
(Ab-192F,  Chemicon International Ltd.,  Harrow,  UK,  
1 : 25 dilution).  Fos immunoreactivity (IR),  which 
indicates neuronal excitation,  was detected as a clear 
ﬂuorescent-red reaction product conﬁned to the 
nucleus of immunopositive neurons,  and cells contain-
ing tyrosine hydroxylase were detected as a pale ﬂuo-
rescent yellowish-green product conﬁned to the cyto-
plasm.
　 Sections were examined and photographed using a 
confocal laser scanning microscope (Zeiss LSM 510,  
Carl Zeiss Microimaging,  Jena,  Germany) and LSM 
image browser.  The most heavily labeled sections 
through each structure of each animal were chosen for 
cell counting.  Cells were counted in a standardized 
manner under 200×magniﬁcation.
　 Statistical analysis. Values are reported as 
mean ± standard deviation (SD).  The rates of Fos-
positive cells/tyrosine-positive cells were evaluated by 
measurement analysis of variance (ANOVA).  When 
indicated by a signiﬁcant F ratio,  the Scheﬀe post-hoc 
test was performed.  A level of p＜0.05 was consid-
ered to be statistically signiﬁcant.
Results
　 Behavior and EEG. After the onset of HBO 
exposure,  a decrease in the activity levels of animals 
was observed,  especially just prior to convulsions.  
Animals stopped moving around and remained in a 
squatting position in the chamber.  On the other hand,  
some animals showed nervous movements such as bit-
ing cables or scratching body parts.
　 All animals in the HBO seizure group showed at 
least one general tonic seizure or electrical discharge 
(EEG seizure) during pressurization,  and 3 of 5 ani-
mals showed wild running.  The average compression 
time was 74.4±26.5min,  and the average time to 
express EEG seizure,  generalized convulsion and wild 
running were 17.41±19.63,  20.98±26.71 and 46.92
±7.92min after reaching a plateau pressure,  respec-
tively.
　 During HBO,  EEG amplitude in both the HBO 
seizure and HBO non-seizure groups was decreased to 
71.7ｵ and 75.3ｵ of the value of the control group,  
although these diﬀerences were not signiﬁcant (p＝
0.084,  0.109,  respectively).  EEG amplitude during 
HBO was signiﬁcantly reduced compared to the pre-
HBO value only in the HBO non-seizure group (p＝
0.043).
　 Fos expression. The regional expression of 
Fos in each group is shown in Fig.  1.  Fos IR was 
remarkably increased in the HBO seizure group and 
slightly increased in the HBO non-seizure group,  but 
extremely low in the control group.  More speciﬁcally 
(Fig.  2),  the HBO seizure group showed signiﬁcantly 
higher Fos IR in A1,  A2 and A6 than that of control 
group (p＜0.001,  0.001,  0.001; respectively),  and 
higher Fos IR in A2 and A6 than that of the HBO 
non-seizure group (p＜0.001,  p＝0.034; respec-
tively).  The HBO non-seizure group exhibited higher 
Fos IR in A1 than the control group (p＜0.001).
Discussion
　 In this study,  we observed the reaction of the brain 
noradrenergic system against HBO exposure and 
examined its contribution to the manifestation of HBO 
seizure.
　 In the HBO non-seizure group,  only A1 noradren-
ergic cells showed signiﬁcantly higher Fos IR than the 
control group,  which suggests the earlier activation of 
A1 cells by HBO exposure.  This early excitement of 
A1 cells can be explained by their higher sensitivity to 
high blood pressure and hyperoxia.  HBO exposure 
causes a signiﬁcant increase of blood pressure and 
decrease of heart rate [18].  A1 cells receive the 
projection from arterial baroreceptors [19,  20] as 
well as from vagal cardiopulmonary volume receptors 
[21].  It is also well known that the noradrenergic 
cells of the caudal ventrolateral medulla (CVLM; A1 
cells) modulate cardiovascular responses [19,  22,  
23].  In the immunohistochemistry,  the HBO seizure 
group showed signiﬁcantly higher Fos IR in A2 and A6 
cells than the HBO non-seizure group.  This result 
suggests that a longer HBO period or HBO seizure 
itself leads to enhancement of Fos activation in this 
area or that the excitement of noradrenergic cells in 
this area may participate in causing or propagating 
HBO seizure.
　 The contribution of noradrenergic reaction to HBO 
seizure has been suggested by the previous ﬁnding that 
administration of a β-adrenergic blocker had an 
inhibitory eﬀect on HBO seizure [17].  The concen-
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tration of noradrenaline in the brain was also reduced 
following HBO seizure [24,  25].  This depletion of 
noradrenaline can be explained by the consequence of 
rapidly increased consumption of noradrenaline caused 
by intense activation of a noradrenergic cascade by 
HBO seizure.  On the other hand,  there still is the 
possibility that the noradrenergic reaction induced the 
HBO seizure.  Further experiments are required to 
clarify this issue.
　 The mechanism of CNS O2 toxicity also involves 
increased production of ROSn [8],  depletion of 
GABA pool [13,  14],  and changes in cortical amino 
acid and NH3 levels [15,  16].  Available evidence 
supports the toxicity of H2O2 during HBO; pre-
administration of an MAO inhibitor reduced the oxy-
gen toxicity due to decreased H2O2 production and 
improved mortality,  and pretreatment with aminotri-
azole,  a reversible inhibitor of catalase which is a 
breakdown enzyme of H2O2,  reinforced the oxygen 
toxicity [25].
　 NO vasodilation,  which results in the increase of 
cerebral blood ﬂow (CBF),  also has a role as a media-
tor of CNS O2 toxicity [11,  12,  26-28].  Administra-
tion of NO synthesis inhibitor reduces CBF and 
results in the decreased incidence of HBO seizure and 
reduced mortality [11,  24,  25].  There is an interac-
tion between O2-dependent noradrenaline metabolism 
and NO synthesis in the CNS as well [25].  Since an 
adequate amount of oxygen is necessary for NO syn-
thesis,  the longer exposure to high-concentration 
oxygen may result in increased NO production.
　 There still remains a question: why only A2 and 
A6 cells,  and not A1 cells,  have the potential for 
dynamic outbreak of neuronal excitement during HBO 
seizure.  This could be explained by the fact that 
increased amplitude of focal EEG by electrical stimu-
lation of the nucleus of solitary tract (A2) is synchro-
nized with rCBF increase,  and that this neuronal 
excitement may expand to the whole brain [29,  30].  
Several drug-induced seizure studies,  which suggested 
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Fig. 1　 Representative appearances of regional expression of Fos.  Markedly higher Fos IR was observed in all HBO seizure groups.  Fos 
IR was slightly increased in the HBO non-seizure group and extremely low in the control group.
that certain brain structures were selectively vulner-
able,  and the earliest and most severe signs of neuro-
pathology would be key sites for the initiation of the 
seizures [31-33],  may also support our ﬁndings;  
Fos expression was observed only in A1 during the 
pre-convulsion period,  and in A2 and A6 post-convul-
sion.
　 In summary,  we have demonstrated that HBO 
treatment activated Fos expression in the noradrener-
gic cells prior to and following HBO seizure.  This 
result suggests that noradrenaline plays an important 
role in the development of HBO-induced seizure in 
rats.
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Fig. 2　 Fos IR expression in areas A1,  A2 and A6.  The HBO non-seizure group exhibited higher Fos IR in A1 than the control group (＊p
＜0.001).  The HBO seizure group showed signiﬁcantly higher Fos IR in A1,  A2 and A6 than the control group (＊＊p＜0.001,  0.001,  
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